Entrada Therapeutics, Inc.(TRDA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRDA Entrada Therapeutics, Inc.

交易中 11-05 11:18:12 EST

17.74

-0.03

-0.20%

最高18.05	最低17.25	成交量2.26万
今开18.05	昨收17.77	日振幅4.50%
总市值6.60亿	流通市值3.59亿	总股本3,720万
成交额39.94万	换手率0.11%	流通股本2,022万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRDA","market":"US","secType":"STK","nameCN":"Entrada Therapeutics, Inc.","latestPrice":17.735,"timestamp":1730823437371,"preClose":17.77,"halted":0,"volume":22577,"delay":0,"floatShares":20215900,"shares":37199550,"eps":3.041531,"marketStatus":"交易中","marketStatusCode":2,"change":-0.035,"latestTime":"11-05 11:18:12 EST","open":18.05,"high":18.05,"low":17.25,"amount":399415.486712,"amplitude":0.04502,"askPrice":18,"askSize":108,"bidPrice":17.72,"bidSize":220,"shortable":3,"etf":0,"ttmEps":3.041531,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1730840400000},"adr":0,"listingDate":1635480000000,"adjPreClose":17.77,"preHourTrading":{"tag":"盘前","latestPrice":17.8,"preClose":17.77,"latestTime":"08:00 EST","volume":141,"amount":2509.8,"timestamp":1730811604426},"postHourTrading":{"tag":"盘后","latestPrice":17.77,"preClose":17.77,"latestTime":"16:02 EST","volume":1689,"amount":30013.53,"timestamp":1730754154673},"volumeRatio":0.946661,"impliedVol":1.4031,"impliedVolPercentile":0.5586},"requestUrl":"/m/hq/s/TRDA","defaultTab":"news","newsList":[{"id":"2478372279","title":"Entrada Therapeutics, Inc.盘中异动 早盘股价大涨5.23%报17.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478372279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478372279?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:07","pubTimestamp":1729868847,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时07分，Entrada Therapeutics, Inc.股票出现波动，股价大幅拉升5.23%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523072798e3e89c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523072798e3e89c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRDA","BK4139","LENZ"],"gpt_icon":0},{"id":"2459901285","title":"Entrada Therapeutics, Inc.盘中异动 早盘快速上涨12.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459901285","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459901285?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:31","pubTimestamp":1723555896,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时31分，Entrada Therapeutics, Inc.股票出现异动，股价快速上涨12.10%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132131369f278d72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132131369f278d72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRDA","BK4139","LENZ"],"gpt_icon":0},{"id":"2458105415","title":"Entrada Therapeutics Inc   预计每股收益14美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458105415","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458105415?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:36","pubTimestamp":1723228606,"startTime":"0","endTime":"0","summary":"   * Entrada Therapeutics Inc    将于8月12日公布截至2024年6月30日的业绩(估计)，预计该公司的季度收入将出现增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于波士顿马萨诸塞州的公司的营收预计将从去年同期的1817万美元增长153.6%，达到4607.5万美元。* LSEG 分析师对 Entrada Therapeutics Inc 的平均预期为每股收益 14 美分。* 华尔街对 Entrada Therapeutics Inc 的 12 个月目标价中位数为 21.50 美元，高于其上次收盘价 14.45 美元。8月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","LENZ"],"gpt_icon":0},{"id":"2457677556","title":"Entrada Therapeutics, Inc.盘中异动 大幅下挫5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457677556","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457677556?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:40","pubTimestamp":1722865216,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时40分，Entrada Therapeutics, Inc.股票出现波动，股价大幅跳水5.22%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.18%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052140169f10745f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052140169f10745f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRDA","BK4139","LENZ"],"gpt_icon":0},{"id":"2456258415","title":"Entrada Therapeutics Inc   预计每股收益14美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456258415","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456258415?lang=zh_cn&edition=full","pubTime":"2024-08-03 01:27","pubTimestamp":1722619641,"startTime":"0","endTime":"0","summary":"   * Entrada Therapeutics Inc    将于8月6日公布截至2024年6月30日的业绩(估计)，预计该公司的季度收入将出现增长。* LSEG 分析师对 Entrada Therapeutics Inc 的平均预期为每股收益 14 美分。* 华尔街对 Entrada Therapeutics Inc 的 12 个月目标价中位数为 21.50 美元，高于其上次收盘价 15.96 美元。8月2日 - 本摘要于北京时间 8 月 2 日 17:27 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","TRDA"],"gpt_icon":0},{"id":"2456284623","title":"Entrada Therapeutics, Inc.盘中异动 快速跳水5.14%报15.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456284623","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456284623?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605477,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分，Entrada Therapeutics, Inc.股票出现波动，股价急速下挫5.14%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213118968233b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213118968233b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRDA","LENZ","BK4139"],"gpt_icon":0},{"id":"2449093387","title":"Entrada Therapeutics, Inc.盘中异动 早盘股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449093387","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449093387?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:09","pubTimestamp":1720447744,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时09分，Entrada Therapeutics, Inc.股票出现波动，股价快速拉升5.24%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082209059681aaaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082209059681aaaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TRDA"],"gpt_icon":0},{"id":"2445271120","title":"Entrada Therapeutics宣布1000万美元注册直接发行。","url":"https://stock-news.laohu8.com/highlight/detail?id=2445271120","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445271120?lang=zh_cn&edition=full","pubTime":"2024-06-24 19:15","pubTimestamp":1719227728,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LENZ","TRDA"],"gpt_icon":0},{"id":"2445798026","title":"Entrada Therapeutics在Duchenne肌肉萎缩症的Entr-601-44-101试验中健康志愿者的初步数据呈现积极态势。","url":"https://stock-news.laohu8.com/highlight/detail?id=2445798026","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445798026?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:00","pubTimestamp":1719223200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","TRDA","LENZ"],"gpt_icon":0},{"id":"2441204720","title":"Entrada Therapeutics, Inc.盘中异动 快速拉升5.56%报16.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441204720","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441204720?lang=zh_cn&edition=full","pubTime":"2024-06-06 02:15","pubTimestamp":1717611335,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日02时15分，Entrada Therapeutics, Inc.股票出现波动，股价大幅拉升5.56%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606021535968123b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606021535968123b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRDA","BK4139","LENZ"],"gpt_icon":0},{"id":"2438517308","title":"Entrada Therapeutics, Inc.盘中异动 大幅拉升5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438517308","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438517308?lang=zh_cn&edition=full","pubTime":"2024-05-28 22:04","pubTimestamp":1716905058,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日22时04分，Entrada Therapeutics, Inc.股票出现波动，股价大幅上涨5.49%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.91%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528220419941eaa0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528220419941eaa0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRDA","LENZ"],"gpt_icon":0},{"id":"2435178105","title":"Entrada Therapeutics, Inc.盘中异动 快速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435178105","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435178105?lang=zh_cn&edition=full","pubTime":"2024-05-14 22:46","pubTimestamp":1715698000,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日22时46分，Entrada Therapeutics, Inc.股票出现波动，股价急速上涨5.09%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142246417927a0fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142246417927a0fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TRDA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.entradatx.com","stockEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.041},{"period":"3month","weight":0.2097},{"period":"6month","weight":0.2648},{"period":"1year","weight":0.0673},{"period":"ytd","weight":0.1776}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Entrada Therapeutics, Inc.于2016年9月22日根据特拉华州法律注册成立。该公司旨在通过将内体逃逸载体(EEV)疗法确立为一种新型药物来改变患者的生活，并致力于成为世界上最重要的细胞内疗法公司。该公司的EEV疗法旨在处理长期以来被认为无法接近和无法成药的细胞内靶标。通过其专有的、高度通用的模块化EEV平台，他们正在构建强大的EEV治疗候选药物开发组合，旨在使治疗剂在各种器官和组织中有效细胞内递送，并提高治疗指数。该公司相信，他们早期项目的潜在成功可以转化为有效开发其他EEV治疗候选药物，并使他们能够在罕见疾病、免疫学和肿瘤学方面建立投资组合。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.16306},{"month":2,"riseRate":0.666667,"avgChangeRate":0.017722},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.00586},{"month":4,"riseRate":0,"avgChangeRate":-0.239764},{"month":5,"riseRate":0.666667,"avgChangeRate":0.13819},{"month":6,"riseRate":0.666667,"avgChangeRate":0.34801},{"month":7,"riseRate":1,"avgChangeRate":0.117995},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.030387},{"month":9,"riseRate":0.666667,"avgChangeRate":0.074673},{"month":10,"riseRate":1,"avgChangeRate":0.177316},{"month":11,"riseRate":0.5,"avgChangeRate":-0.063209},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.119508}],"exchange":"NASDAQ","name":"Entrada Therapeutics, Inc.","nameEN":"Entrada Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Entrada Therapeutics, Inc.(TRDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Entrada Therapeutics, Inc.(TRDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Entrada Therapeutics, Inc.,TRDA,Entrada Therapeutics, Inc.股票,Entrada Therapeutics, Inc.股票老虎,Entrada Therapeutics, Inc.股票老虎国际,Entrada Therapeutics, Inc.行情,Entrada Therapeutics, Inc.股票行情,Entrada Therapeutics, Inc.股价,Entrada Therapeutics, Inc.股市,Entrada Therapeutics, Inc.股票价格,Entrada Therapeutics, Inc.股票交易,Entrada Therapeutics, Inc.股票购买,Entrada Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Entrada Therapeutics, Inc.(TRDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Entrada Therapeutics, Inc.(TRDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}